4//SEC Filing
Oxtoby Andrew 4
Accession 0000899243-19-001869
CIK 0001631650other
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 4:06 PM ET
Size
7.8 KB
Accession
0000899243-19-001869
Insider Transaction Report
Form 4
Oxtoby Andrew
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.0001 par value
2019-01-22+12,000→ 12,000 total - Award
Stock Option (right to buy)
2019-01-22+150,000→ 150,000 totalExercise: $21.94Exp: 2029-01-22→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from January 22, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F2]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on January 22, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001765473
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 4:06 PM ET
- Size
- 7.8 KB